VGP NV (VGP)
Euronext Brussels · Belgium · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 62.20 |
|---|---|
| 52-week range | 61.30 – 111.20 |
| Return, 1 month / 3 months | −11.8% / −25.2% |
| Return, 1 year / 3 years | −36.8% / −4.0% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 29.4% |
| Worst drawdown (1 year) | -39.7% |
| Average daily value traded | 2.05M EUR |
| Dividend yield | 10.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
VGP is a Belgian property company that develops and owns industrial and logistics parks, mainly in Europe. It builds warehouses and light industrial buildings and leases them to businesses that need space for storage, distribution and light manufacturing. The company also manages its parks and related land over the long term. VGP is based in Antwerp, Belgium, and its properties serve tenants in several European countries.
On this site VGP NV appears as a stock on the Euronext Brussels (Belgium), code VGP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
VGP NV (VGP) trades on the Euronext Brussels in Belgium. It last closed at EUR 62.20 on 23 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 81 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 36.8% and over the last three months it fell 25.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 19 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.4% | ||
| From 52-week high | -44.0% | ||
| Momentum | 15 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.2% | ||
| 6-month return | -25.9% | ||
| 12-month return, skipping the last month | -28.4% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.7% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 2.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | −11.8% |
| 3 months | −25.2% |
| 6 months | −25.9% |
| 1 year | −36.8% |
| 3 years | −4.0% |
| 5 years | −63.2% |
Signals
| 50-day / 200-day average | 71.43 / 82.28 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 May 2026 | EUR 3.4000 |
| 8 May 2026 | EUR 3.4000 |
| 21 May 2025 | EUR 3.3000 |
| 22 May 2024 | EUR 3.7000 |
| 24 May 2023 | EUR 2.7500 |
| 23 May 2022 | EUR 6.7865 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.